The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejpb.2015.04.039PMID 25986585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

  2017cited by this paper
• Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.

  2015cited by this paper
• Clinical and Genetic Factors Associated with Progression of Geographic Atrophy Lesions in Age-Related Macular Degeneration

  2015cited by this paper
• Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections

  2014cited by this paper
• Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue

  2014cited by this paper
• Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study.

  2014cited by this paper
• Recent developments in the treatment of age-related macular degeneration.

  2014cited by this paper
• A Novel Antibody against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin from Blood Samples

  2014cited by this paper
• Stem cells as source for retinal pigment epithelium transplantation.

  2014cited by this paper
• Beta cyclodextrins bind, stabilize, and remove lipofuscin bisretinoids from retinal pigment epithelium

  2014cited by this paper
• The role of the complement system in age-related macular degeneration.

  2014cited by this paper
• Protective Role for Properdin in Progression of Experimental Murine Atherosclerosis

  2014cited by this paper
• Epimacular brachytherapy for wet AMD: current perspectives

  2014cited by this paper
• Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application

  2014cited by this paper
• Nanosecond‐laser application in intermediate AMD: 12‐month results of fundus appearance and macular function

  2014cited by this paper
• Genetic risk models in age-related macular degeneration.

  2014cited by this paper
• Allergy is a protective factor against age-related macular degeneration.

  2014cited by this paper
• Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

  2014cited by this paper
• Impact of the Common Genetic Associations of Age-Related Macular Degeneration upon Systemic Complement Component C3d Levels

  2014cited by this paper
• Age-related macular degeneration: genetics and biology coming together.

  2014cited by this paper
• Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).

  2013cited by this paper
• Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.

  2013cited by this paper
• The NHGRI GWAS Catalog, a curated resource of SNP-trait associations

  2013cited by this paper
• Seven New Loci Associated with Age-Related Macular Degeneration

  2013cited by this paper
• A functional variant in the CFI gene confers a high risk of age-related macular degeneration

  2013cited by this paper
• Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.

  2013cited by this paper
• Therapies for Neovascular Age-Related Macular Degeneration: Current Approaches and Pharmacologic Agents in Development

  2013cited by this paper
• Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration: A Genome-Wide Association Study Meta-Analysis

  2013cited by this paper
• Treatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trial.

  2013cited by this paper
• Identification of a Rare Coding Variant in Complement 3 Associated with Age-related Macular Degeneration

  2013cited by this paper
• Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration

  2013cited by this paper
• A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration

  2013cited by this paper
• Retinal damage profiles and neuronal effects of laser treatment: comparison of a conventional photocoagulator and a novel 3-nanosecond pulse laser.

  2013cited by this paper
• Beyond GWASs: illuminating the dark road from association to function.

  2013cited by this paper
• Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration

  2013cited by this paper
• Turning a blind eye to anti-VEGF toxicities.

  2012cited by this paper
• Embryonic stem cell trials for macular degeneration: a preliminary report.

  2012cited by this paper
• Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

  2012cited by this paper
• A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene.

  2012cited by this paper
• Targeted deletion of Vegfa in adult mice induces vision loss.

  2012cited by this paper
• Modelling the Genetic Risk in Age-Related Macular Degeneration

  2012cited by this paper
• Animal models of age related macular degeneration.

  2012cited by this paper
• Prevalence of age‐related macular degeneration in persons aged 90 years and older in Cologne

  2012cited by this paper
• Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.

  2012cited by this paper
• Global estimates of visual impairment: 2010

  2011cited by this paper
• Correction for multiple testing: is there a resolution?

  2011cited by this paper
• Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study.

  2011cited by this paper
• Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration

  2011cited by this paper
• A rare penetrant mutation in CFH confers high risk of age-related macular degeneration

  2011cited by this paper
• Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration

  2011cited by this paper
• Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

  2011cited by this paper
• Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.

  2011cited by this paper
• Risk assessment model for development of advanced age-related macular degeneration.

  2011cited by this paper
• Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people.

  2011cited by this paper
• Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency.

  2011cited by this paper
• Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

  2010cited by this paper
• PATHWAY-BASED THERAPIES FOR AGE-RELATED MACULAR DEGENERATION: An Integrated Survey of Emerging Treatment Alternatives

  2010cited by this paper
• Progression of geographic atrophy and genotype in age-related macular degeneration.

  2010cited by this paper
• An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).

  2010cited by this paper
• Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration.

  2010cited by this paper
• Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review

  2010cited by this paper
• Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.

  2010cited by this paper
• Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.

  2009cited by this paper
• CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD

  2009cited by this paper
• Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.

  2009cited by this paper
• Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B

  2009cited by this paper
• VEGF inhibition and renal thrombotic microangiopathy.

  2008cited by this paper
• C3 R102G polymorphism increases risk of age-related macular degeneration.

  2008cited by this paper
• Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA

  2008cited by this paper
• Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

  2007cited by this paper
• Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

  2006cited by this paper
• Role of genes and environments for explaining Alzheimer disease.

  2006cited by this paper
• Apolipoprotein (APOE) gene is associated with progression of age‐related macular degeneration (AMD)

  2006cited by this paper
• Genetics of obesity and the prediction of risk for health.

  2006cited by this paper
• Complement: a novel factor in basal and ischemia‐induced neurogenesis

  2006cited by this paper
• Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

  2006cited by this paper
• Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

  2006cited by this paper
• Dietary intake of antioxidants and risk of age-related macular degeneration.

  2005cited by this paper
• Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.

  2005cited by this paper
• Modelling the Natural History of Geographic Atrophy in Patients with Age-Related Macular Degeneration

  2005cited by this paper
• The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences.

  2005cited by this paper
• Susceptibility genes for age-related maculopathy on chromosome 10q26.

  2005cited by this paper
• Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center.

  2004cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines

  2003cited by this paper
• Genetic influence on early age-related maculopathy: a twin study.

  2002cited by this paper
• THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY

  2001cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death

  2001cited by this paper
• Genetic and environmental factors in epilepsy: a population-based study of 11900 Danish twin pairs.

  2001cited by this paper
• A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration.

  2000cited by this paper
• Effects of doxycycline on human prostate cancer cells in vitro.

  1998cited by this paper
• Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration

  1998cited by this paper
• Genetic association of apolipoprotein E with age-related macular degeneration.

  1998cited by this paper
• Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.

  1997cited by this paper
• Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration

  1997cited by this paper
• Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

  1988cited by this paper

• Differential Organ Ageing Is Associated With Age‐Related Macular Degeneration

  2025cites this paper
• Integrative analysis and knowledgebase construction of key candidate genes and pathways in age-related macular degeneration.

  2024cites this paper
• The Impact of NF-κB on Inflammatory and Angiogenic Processes in Age-Related Macular Degeneration.

  2024cites this paper
• Functional role of translocator protein and its ligands in ocular diseases (Review)

  2024cites this paper
• LONGL-Net: temporal correlation structure guided deep learning model to predict longitudinal age-related macular degeneration severity

  2022cites this paper
• Characterization and identification of measurable endpoints in a mouse model featuring age-related retinal pathologies: a platform to test therapies

  2022cites this paper
• Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina

  2021cites this paper
• Treat and extend paradigm in management of neovascular age-related macular degeneration: current practice and future directions

  2021cites this paper
• Complement System and Potential Therapeutics in Age-Related Macular Degeneration

  2021cites this paper
• Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice, implication for age-related macular degeneration.

  2021cites this paper
• A Circulating MicroRNA Profile in a Laser-Induced Mouse Model of Choroidal Neovascularization

  2020cites this paper
• Design and application of dextran carrier

  2020cites this paper
• Progression of geographic atrophy with subsequent exudative neovascular disease in age-related macular degeneration: AREDS2 Report 24.

  2020cites this paper
• TRIM31 inhibits NLRP3 inflammasome and pyroptosis of retinal pigment epithelial cells through ubiquitination of NLRP3

  2020cites this paper
• Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration.

  2019cites this paper
• Therapeutic potential of curcumin in major retinal pathologies

  2019cites this paper
• Highly bioactive, bevacizumab‐loaded, sustained‐release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases

  2019cites this paper
• Insights into the loss of the Y chromosome with age in control individuals and in patients with age-related macular degeneration using genotyping microarray data

  2019cites this paper
• Deep-learning-based Prediction of Late Age-Related Macular Degeneration Progression

  2019cites this paper
• A Deep Learning Algorithm for Prediction of Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration from Color Fundus Photography.

  2018cites this paper
• A mega-analysis of expression quantitative trait loci (eQTL) provides insight into the regulatory architecture of gene expression variation in liver

  2018cites this paper
• Y chromosome mosaicism is associated with age-related macular degeneration

  2018cites this paper
• Pharmacokinetic aspects of retinal drug delivery.

  2017cites this paper
• Retinal Degeneration and Regeneration—Lessons From Fishes and Amphibians

  2017cites this paper
• Macular Degeneration Epidemiology: Nature-Nurture, Lifestyle Factors, Genetic Risk, and Gene-Environment Interactions – The Weisenfeld Award Lecture

  2017cites this paper
• Schwerpunktthema : Therapiestrategien bei erblichen Netzhauterkrankungen

  2017cites this paper
• Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages

  2016cites this paper
• Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization

  2016cites this paper
• Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics

  2016cites this paper
• An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology

  2016cites this paper
• Distinct Genetic Risk Profile of the Rapidly Progressing Diffuse-Trickling Subtype of Geographic Atrophy in Age-Related Macular Degeneration (AMD).

  2016cites this paper
• Photodegradation of retinal bisretinoids in mouse models and implications for macular degeneration

  2016cites this paper
• Drugs Used in Ocular Treatment

  2016cites this paper
• Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD)

  2016cites this paper
• Genetisches Risiko bei der altersabhängigen Makuladegeneration

  2015cites this paper
• Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects

  2015cites this paper
• Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects

  2015cites this paper